2028年までのアジア太平洋地域の皮下注射針市場予測 - 新型コロナウイルス感染症（COVID-19）の影響と種類別（安全針、非安全針）、用途別（ドラッグデリバリー、ワクチン接種、血液検体採取）、エンドユーザー別（診断センター、病院）の地域分析およびクリニック、在宅医療）、および用途（使い捨ておよび再利用可能）
No. of Pages: 140 | Report Code: TIPRE00026207 | Category: Life Sciences
No. of Pages: 140 | Report Code: TIPRE00026207 | Category: Life Sciences
皮下注射針の需要は、新型コロナウイルス感染症（COVID-19）に対するワクチンの接種が増加している。したがって、市場関係者は、新型コロナウイルス感染症パンデミックの中で市場開発活動に積極的に参加しています。例えば、ミサワ医科工業株式会社は2021年4月、注射器内の薬液残量を低減できる「ローデッドスペースニードル」を開発し、2021年4月1日より日本で販売を開始します。特定のシリンジの必要性がなくなり、シリンジ内に液体が残る「デッドスペース」が減少します。さらに、ファイザー社が開発した新型コロナウイルスワクチンは1バイアルで6回分の注射が可能だ。ミサワ医科工業株式会社は2020年6月に針製造設備を増設し、年間生産能力を19億本から30億本に増強した。同社は現在、他の製品生産ラインを活用しながらワクチン針の生産体制を強化しており、今後もワクチン接種を容易にする取り組みを継続してまいります。
新しい機能とテクノロジーを使用することで、ベンダーは新しい顧客を引き付け、新興市場での拠点を拡大できます。この要因が皮下注射針市場を牽引する可能性があります。アジア太平洋地域の皮下注射針市場は、予測期間中に良好な CAGR で成長すると予想されます。
アジア太平洋地域の皮下注射針市場の収益と 2028 年までの予測(百万米ドル)
アジア太平洋地域の皮下注射針市場セグメンテーション
記載されている企業
Strategic insights for Asia Pacific Hypodermic Needles involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 668.7 Million |
| Market Size by 2028 | US$ 1,092.6 Million |
| Global CAGR (2021 - 2028) | 7.3% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By タイプ
|
| Regions and Countries Covered | アジア太平洋
|
| Market leaders and key company profiles |
The regional scope of Asia Pacific Hypodermic Needles refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Hypodermic Needles Market is valued at US$ 668.7 Million in 2021, it is projected to reach US$ 1,092.6 Million by 2028.
As per our report Asia Pacific Hypodermic Needles Market, the market size is valued at US$ 668.7 Million in 2021, projecting it to reach US$ 1,092.6 Million by 2028. This translates to a CAGR of approximately 7.3% during the forecast period.
The Asia Pacific Hypodermic Needles Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Hypodermic Needles Market report:
The Asia Pacific Hypodermic Needles Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Hypodermic Needles Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Hypodermic Needles Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Hypodermic Needles Market
